Clinical Trial Update: Assesment of the Immune Response to RSV Vaccine in Patients With Myeloma, Lymphoma and Hematological Leukemia

View source ↗

Summary

This clinical trial update assesses the immune response to an RSV vaccine in patients with hematologic cancers, including multiple myeloma, lymphoma, chronic ly…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Chronic Lymphocytic Leukemia
• Lymphoma
• Multiple Myeloma
• Myelodysplastic Syndromes

Drugs mentioned

• RSV vaccine (respiratory syncytial virus vaccine)

Snippet

Sponsor: Tel-Aviv Sourasky Medical Center | Conditions: Myeloma, Lymphoma | Status: ACTIVE_NOT_RECRUITING